Medical Marijuana Gets Mixed Reviews
A review published in the Journal of the American Medical Association (JAMA) suggests that the benefits of medical marijuana are not the same for all the conditions it is approved to treat.
Scientists analyzed 80 trials studying more than 6,500 people. Overall, they found moderate support for using medical marijuana to treat chronic pain and involuntary muscle spasms, but noted that the drug was less beneficial for other conditions it’s prescribed for, such as nausea and vomiting from chemotherapy, sleep disorders, HIV weight-loss therapy, and Tourette syndrome.
Researchers also noted that when using medical marijuana, it’s important that patients consider the associated risks, such as dizziness, dry mouth, nausea, as well as the possible risk of psychosis due to long-term use. The researchers say these reviews help to provide doctors with an outline of evidence to help them decide which conditions should be prescribed medical marijuana as treatment. These reviews also serve to provide a check on the process of how medical marijuana is approved for certain conditions in the U.S. by the Food and Drug Administration (FDA).
In a different study from Johns Hopkins University published in the same journal, fewer than five out of 75 edible marijuana products were found to be labeled correctly when it came to reporting the level of THC in those products.